🔶PSA screening rates 📉 among men aged 40 years or older in the US Veterans Health Administration
🔶Facilities with higher PSA screening rates had lower subsequent rates of metastatic #prostatecancer

JAMA Oncology OncoAlert Prostate Cancer Foundation European Association of Urology (EAU) ASCO National Comprehensive Cancer Network (NCCN)

jamanetwork.com/journals/jamao…

Congratulations Jonathan (the ultimate Jonathan Tward) to your innovative research using deep learning in digital histopathology! University of Utah Radiation Oncology Huntsman Cancer Institute GU Cancer Research Program @HuntsmanCancer Neeraj Agarwal

A very happy Diwali to all who celebrate. #ASTRO22

💫Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami
Sumanta Pal
Neeraj Agarwal
OncoAlert
OncoReporte frontiersin.org/articles/10.33…

Dear #ASTRO22 ASTRO ⭐️
We're OncoAlert🚨
Gil Morgan
Toni Choueiri, MD Vivek Subbiah, MD Neeraj Agarwal Darcy Burbage, DNP, RN, AOCN J. De Munter Jill Feldman Mark Lewis Andreas Charalambous Stephen V Liu, MD Matteo Lambertini, MD PhD Dr. Cathy Eng Icro Meattini Yelena Y. Janjigian MD LENA SHARP Tom Powles Rana McKay

Does timing ⏳ matter?

When short-term ADT is used with prostate-only radiation ☢️ , concurrent/adjuvant ADT should be the standard of care. #prostatecancer
Amar Kishan Daniel E Spratt Journal of Clinical Oncology APCCC22 ASCO ESMO - Eur. Oncology OncoAlert UroToday.com European Association of Urology (EAU)

Sarmad Sadeghi presents on phase III S1937 trial at the fall SWOG Cancer Research Network meeting. An important trial evaluating eribulin +/- gemcitabine as subsequent line therapy for metastatic urothelial carcioma.
swog.org/clinical-trial…

What happens in Greece..Stays in Greece🇬🇷

So Not True‼️

Very Proud to announce that we are taking with us a NEW OncoAlert🚨Faculty🌐

A warm welcome to the awesome Tom Powles 🇬🇧and beyond honoured to have him in the Network🙌

Beautiful talk by Parminder singh at the 1st #Vogelzang SWOG Cancer Research Network Symposium. He highlights the common elements of successful studies (simple eligibility, simple design) w examples from Neeraj Agarwal (S1216), Thomas Flaig (S1314) & his own study (S1806) w Peter Black.

Hope to see many of you this AM at this SWOG Cancer Research Network symposium dedicated to our dear friend/mentor/colleague #NickVogelzang . It was National Cancer Institute cooperative group mtgs that brought us together; through them his legacy will live on. Daniel Petrylak Neelima Denduluri Neeraj Agarwal Ulka Vaishampayan

The amazing Petros Grivas 🇬🇷knocks it out of the park at the 3rd Athenian Oncology Congress‼️

#IO in advanced Urothelial cancer

Chairs Marita Lykka MD & Marinos Tsiatas

Excited to see progress w SWOG Cancer Research Network Clinical Trial Partnerships, w exceptional leadership from #DrKathyAlbain . I've been doing peer reviews & seen some incredible designs come thru! I spy #DrBlanke , Manmeet Ahluwalia, MD, MBA & others in the audience. Joining virtually today but onsite tomorrow!

JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy: The IMDC does it again ! #IMDC Daniel Heng with Talal El Zarif, MD Ziad Bakouny, MD, MSc Shaan Dudani et al in European Urology

secure-web.cisco.com/1nOqqWr2rKW30O…

This is SO amazing!!! Three nominees from Huntsman Cancer Institute were honored with this year's Cancer Community Awards!!! Congratulations to David Wetter, Doug Fair, and Charles R. Rogers, PhD, MPH, MS, MCHES! This fully attests to the work we do here, dedicated to the communities we serve! HCI Community Outreach and Engagement University of Utah

🔺Wow ! Used to always wonder about this. Differential mosquito attraction to humans is associated with skin-derived carboxylic acid levels. Do we need personalized repellents based on skin acid levels ? Cell Cell Press cell.com/cell/fulltext/…